NTRA Natera Inc

Price (delayed)

$56.65

Market cap

$6.42B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.57

Enterprise value

$6.39B

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a ...

Highlights
NTRA's equity has surged by 95% since the previous quarter and by 8% year-on-year
NTRA's revenue is up by 31% year-on-year and by 6% since the previous quarter
The quick ratio has increased by 30% since the previous quarter but it has declined by 22% year-on-year
The EPS has decreased by 7% YoY but it has increased by 2.1% from the previous quarter
Natera's net income has decreased by 16% YoY
The company's debt rose by 12% YoY and by 7% QoQ

Key stats

What are the main financial stats of NTRA
Market
Shares outstanding
113.29M
Market cap
$6.42B
Enterprise value
$6.39B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.83
Price to sales (P/S)
6.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.79
Earnings
Revenue
$820.22M
EBIT
-$537.5M
EBITDA
-$507.03M
Free cash flow
-$479.2M
Per share
EPS
-$5.57
Free cash flow per share
-$4.87
Book value per share
$7.23
Revenue per share
$8.33
TBVPS
$14.17
Balance sheet
Total assets
$1.39B
Total liabilities
$688.73M
Debt
$438.58M
Equity
$705.74M
Working capital
$901.32M
Liquidity
Debt to equity
0.62
Current ratio
3.9
Quick ratio
3.68
Net debt/EBITDA
0.05
Margins
EBITDA margin
-61.8%
Gross margin
44.4%
Net margin
-66.8%
Operating margin
-66%
Efficiency
Return on assets
-47.5%
Return on equity
-106.7%
Return on invested capital
-48.6%
Return on capital employed
-49.6%
Return on sales
-65.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NTRA stock price

How has the Natera stock price performed over time
Intraday
1.71%
1 week
0.04%
1 month
18.69%
1 year
39.36%
YTD
41.03%
QTD
41.03%

Financial performance

How have Natera's revenue and profit performed over time
Revenue
$820.22M
Gross profit
$363.97M
Operating income
-$541.04M
Net income
-$547.8M
Gross margin
44.4%
Net margin
-66.8%
NTRA's revenue is up by 31% year-on-year and by 6% since the previous quarter
Natera's gross profit has increased by 19% YoY and by 3.1% QoQ
Natera's operating income has decreased by 16% YoY
Natera's net income has decreased by 16% YoY

Growth

What is Natera's growth rate over time

Valuation

What is Natera stock price valuation
P/E
N/A
P/B
7.83
P/S
6.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.79
The EPS has decreased by 7% YoY but it has increased by 2.1% from the previous quarter
NTRA's equity has surged by 95% since the previous quarter and by 8% year-on-year
The stock's P/B is 74% less than its 5-year quarterly average of 29.8 and 2.1% less than its last 4 quarters average of 8.0
NTRA's price to sales (P/S) is 31% higher than its last 4 quarters average of 5.2 but 28% lower than its 5-year quarterly average of 9.5
NTRA's revenue is up by 31% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Natera business performance
The return on invested capital has declined by 24% year-on-year and by 6% since the previous quarter
The ROE has contracted by 18% YoY but it has grown by 2.2% from the previous quarter
The ROS has increased by 11% YoY and by 5% from the previous quarter
The ROA is down by 8% year-on-year but it is up by 3.1% since the previous quarter

Dividends

What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRA.

Financial health

How did Natera financials performed over time
NTRA's total assets is 102% higher than its total liabilities
NTRA's total assets is up by 38% QoQ and by 13% YoY
The quick ratio has increased by 30% since the previous quarter but it has declined by 22% year-on-year
The company's debt is 38% lower than its equity
NTRA's equity has surged by 95% since the previous quarter and by 8% year-on-year
The debt to equity has contracted by 45% from the previous quarter but it has grown by 3.3% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.